Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
Purpose: Clevidipine is a rapidly-acting intravenous dihydropyridine antihypertensive acting via calcium channel blockade. This was a randomized, single-blind, parallel-design study of a 72-h continuous clevidipine infusion. Method: Doses of 2, 4, 8, or 16.0 mg/h or placebo were evaluated in 61 subj...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 68; no. 10; pp. 1385 - 1395 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Oct2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |